Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2018 | Cytokine release syndrome in CAR T-cell therapy

Rose Ellard • 18 Mar 2018
EBMT 2018
General CAR-T

CAR T-cell therapy is a new and exciting advancement for the treatment of hematological cancers. In this interview, Rose Ellard from King’s College Hospital NHS Foundation Trust, London, UK, talks about the breakthrough clinical trials for CAR T-cell agents currently being held in the UK, and the management of potential side effects. Cytokine release syndrome, for example, requires prompt recognition of the symptoms and management with specialist care. This video was recorded at the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal.

More from Rose Ellard

1:27
Becoming CAR-T educated
Rose Ellard • 27 Sep 2019
1:26
EBMT guidelines CAR-T education & guidelines for nurses
Rose Ellard • 2 Aug 2019
1:34
CAR-T: symptoms and their assessment
Rose Ellard • 15 Feb 2019
1:16
CAR-T treatment journey and the role of the nurse
Rose Ellard • 15 Feb 2019

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals